The AstraZeneca jab is largely considered Latin America’s most viable vaccine option, with both Mexico and Argentina signing agreements with the pharmaceutical giant to produce the vaccine.
The AstraZeneca jab is largely considered Latin America’s most viable vaccine option, with both Mexico and Argentina signing agreements with the pharmaceutical giant to produce the vaccine.